Molecular profiling of frontal and occipital subcortical white matter hyperintensities in Alzheimer's disease

Sulochan Malla1,2, Annie G Bryant1,3, Rojashree Jayakumar1

  • 1Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

Insights

Investigating white matter hyperintensities (WMH) in Alzheimer's disease (AD) reveals distinct molecular signatures. Our study uncovers key gene expression changes in AD white matter, offering new insights into disease mechanisms.

Area of Science:

  • Neuroscience
  • Genomics
  • Biochemistry

Background:

  • White matter hyperintensities (WMH) are common in aging and Alzheimer's disease (AD), linked to cognitive decline.
  • The molecular drivers of WMH in AD remain largely unknown.
  • Understanding these molecular changes is crucial for developing targeted therapies.

Purpose of the Study:

  • To characterize the transcriptomic profiles of white matter in AD.
  • To compare gene expression in frontal and occipital white matter between AD patients and healthy controls.
  • To identify molecular pathways associated with WMH burden in AD.

Main Methods:

  • RNA-sequencing of bulk white matter tissue from frontal and occipital regions.
  • Isolation and RNA-sequencing of blood vessels from white matter.
  • Differential gene expression analysis comparing AD and control groups, and high vs. low WMH burden groups.

Main Results:

  • Upregulation of vasculature-associated genes in AD white matter.
  • Upregulation of protein folding pathway genes in isolated white matter blood vessels.
  • Increased expression of immune function pathways in AD individuals with higher WMH burden.

Conclusions:

  • AD white matter exhibits unique transcriptomic alterations compared to normal aging.
  • Specific pathways, including vascular, protein folding, and immune functions, are implicated in AD-related WMH.
  • These findings provide novel mechanistic insights into AD pathogenesis and WMH development.